Sentence examples for both studies are shown from inspiring English sources

Subject characteristics for both studies are shown in Table 1.

Pharmacodynamic outcomes from both studies are shown in Table 1.

The demographic and baseline characteristics of the subjects in both studies are shown in Table S1.

Examples of improvements in eyelash length, thickness, and darkness for bimatoprost-treated subjects in both studies are shown in Fig.  4.

The number of statistically significant (P < 0.05) metabolic features for each comparison and animal study and the number of metabolic features observed as statistically significant in both studies are shown in Table 1.

The age, sex, level of social deprivation and BMI of included participants from both studies are shown in table 1. Table 2 shows levels of different physical activity constructs across White and SA groups by self-reported and objective measurements.

The full set of tumours from both studies is shown in Additional Files 2 and 3.

Thyroid profile data for both studies is shown in Table  1.

The distribution of SHIP© questionnaire scores from both SHIP Oral and SHIP Premix studies are shown in Table 2.

That, at least, is what the current studies are showing.

One model that would be consistent with the outcome of both previous studies is shown in Scheme 2. In this mechanism, a hydroperoxylation process is followed by a Criegee rearrangement (step 4) and hydrolysis to form HMP (step 5), as previously proposed.